The 6th Age-Related Disease Therapeutics Summit is the leading global meeting dedicated to advancing therapies that target the biology of aging and age-related diseases.

Over three days, the summit brings together senior decision-makers from biopharma, biotech innovators, investors, and academic researchers to accelerate the development and commercialization of next-generation therapeutics.

As the aging population grows, the demand for interventions that extend healthspan and treat chronic conditions is at an all-time high. This meeting provides a unique platform for professionals to explore cutting-edge science, clinical progress, and translational strategies shaping this rapidly evolving field.

From senolytics and cellular rejuvenation to mitochondrial health and systemic inflammation, the summit covers the most promising approaches in age-related disease treatment.

Key highlights include:

• Deep-dive sessions on therapeutic targets, biomarker validation, and regulatory pathways.
• Investment & Funding Insights: Hear from leading investors and strategists on where capital is flowing in longevity and age-related disease innovation.
• Networking Opportunities: Connect with C-suite executives, R&D leaders, and pioneering scientists driving breakthroughs in aging biology.

Here are just some of the ground-breaking companies that will be presenting this year:

Age 1 | BioAge Labs | Biolexis Therapeutics | Gordian Biotechnology | Insilico Medicine | Juvenescence | Kendall Capital Partners | Novartis | Rubedo Life Sciences | Telocyte

Find out more, here: https://ter.li/b3tokv